Written by HealthDay News
Updated on March 09, 2007
HealthDay operates under the strictest editorial standards. Our syndicated news content is completely independent of any financial interests, is based solely on industry-respected sources and the latest scientific research, and is carefully fact-checked by a team of industry experts to ensure accuracy.
- All articles are edited and checked for factual accuracy by our Editorial Team prior to being published.
- Unless otherwise noted, all articles focusing on new research are based on studies published in peer-reviewed journals or issued from independent and respected medical associations, academic groups and governmental organizations.
- Each article includes a link or reference to the original source.
- Any known potential conflicts of interest associated with a study or source are made clear to the reader.
Please see our Editorial and Fact-Checking Policy for more detail.Editorial and Fact-Checking Policy
HealthDay Editorial Commitment
HeathDay is committed to maintaining the highest possible levels of impartial editorial standards in the content that we present on our website. All of our articles are chosen independent of any financial interests. Editors and writers make all efforts to clarify any financial ties behind the studies on which we report.
(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:
This study will examine possible causes of miscarriage. Couples evaluated by researchers for a history of pregnancy loss may be asked to participate. Permission will be sought to allow testing of genetic material from miscarriage tissue using a newer, more powerful technology. To be eligible, participants must have had at least two unexplained, consecutive miscarriages of less than 12 weeks with the same partner; a normal chromosome test result for the most recent miscarriage; and both parents able to undergo testing.
The research site is in Chicago, Ill.
This study will evaluate the effectiveness of a vaginal cream on atrophic vaginitis. Participants will receive at no cost study related exams, lab work, investigational cream, and financial compensation for time and travel.
The research site is in Philadelphia, Penn.
Allergies & Asthma
You may be eligible for this clinical study if you are between12-75 years of age, have allergic asthma, and are being treated with medication for the condition. Compensation for participation is included.
The research site is in St. Louis, Mo.
Copyright 2007 Thomson CenterWatch. All rights reserved.
This story may be outdated. We suggest some alternatives.
The content contained in this article is over two years old. As such our recommendation is that you reference the articles below for the latest updates on this topic. This article has been left on our site as a matter of historic record. Please contact us at email@example.com with any questions.